Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

cylindromatosis (turban tumor syndrome), Mouse, Clone: 2C3, Abnova™

Mouse monoclonal antibody raised against a partial recombinant CYLD.

Supplier:  Abnova Corporation H00001540M01

Catalog No. 89-014-086


Only null left
Add to Cart

Description

Description

This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq

Sequence: QNMELFAVLCIETSHYVAFVKYGKDDSAWLFFDSMADRDGGQNGFNIPQVTPCPEVGEYLKMSLEDLHSLDSRRIQGCARRLLCDAYMCMYQSPTMSLYK
Specifications

Specifications

cylindromatosis (turban tumor syndrome)
Monoclonal
Unconjugated
PBS with no preservative; pH 7.4
BC012342
CYLD
CYLD (AAH12342, 854 a.a. ∼ 953 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
100 μg
Cell Cycle
1540
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
IgG2a κ
ELISA, Immunofluorescence
2C3
Mouse monoclonal antibody raised against a partial recombinant CYLD.
CYLD
CDMT/CYLD1/CYLDI/EAC/FLJ20180/FLJ31664/FLJ78684/HSPC057/KIAA0849/MFT/MFT1/SBS/TEM/USPL2
Mouse
Affinity Purified
RUO
Primary
Human
Antibody
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.